19-10806008-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001005361.3(DNM2):​c.1545+41C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.168 in 1,613,244 control chromosomes in the GnomAD database, including 24,287 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.13 ( 1613 hom., cov: 32)
Exomes 𝑓: 0.17 ( 22674 hom. )

Consequence

DNM2
NM_001005361.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -3.79

Publications

16 publications found
Variant links:
Genes affected
DNM2 (HGNC:2974): (dynamin 2) Dynamins represent one of the subfamilies of GTP-binding proteins. These proteins share considerable sequence similarity over the N-terminal portion of the molecule, which contains the GTPase domain. Dynamins are associated with microtubules. They have been implicated in cell processes such as endocytosis and cell motility, and in alterations of the membrane that accompany certain activities such as bone resorption by osteoclasts. Dynamins bind many proteins that bind actin and other cytoskeletal proteins. Dynamins can also self-assemble, a process that stimulates GTPase activity. Five alternatively spliced transcripts encoding different proteins have been described. Additional alternatively spliced transcripts may exist, but their full-length nature has not been determined. [provided by RefSeq, Jun 2010]
DNM2 Gene-Disease associations (from GenCC):
  • autosomal dominant centronuclear myopathy
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics, Orphanet
  • Charcot-Marie-Tooth disease
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • Charcot-Marie-Tooth disease dominant intermediate B
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • autosomal dominant Charcot-Marie-Tooth disease type 2M
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • fetal akinesia-cerebral and retinal hemorrhage syndrome
    Inheritance: AR Classification: SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
  • hereditary spastic paraplegia
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 19-10806008-C-T is Benign according to our data. Variant chr19-10806008-C-T is described in ClinVar as Benign. ClinVar VariationId is 256865.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.174 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001005361.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DNM2
NM_001005361.3
MANE Select
c.1545+41C>T
intron
N/ANP_001005361.1P50570-4
DNM2
NM_001005360.3
c.1545+41C>T
intron
N/ANP_001005360.1P50570-1
DNM2
NM_001190716.2
c.1545+41C>T
intron
N/ANP_001177645.1P50570-5

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DNM2
ENST00000389253.9
TSL:5 MANE Select
c.1545+41C>T
intron
N/AENSP00000373905.4P50570-4
DNM2
ENST00000355667.11
TSL:1
c.1545+41C>T
intron
N/AENSP00000347890.6P50570-1
DNM2
ENST00000585892.5
TSL:1
c.1545+41C>T
intron
N/AENSP00000468734.1P50570-5

Frequencies

GnomAD3 genomes
AF:
0.130
AC:
19810
AN:
152070
Hom.:
1613
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0367
Gnomad AMI
AF:
0.261
Gnomad AMR
AF:
0.123
Gnomad ASJ
AF:
0.199
Gnomad EAS
AF:
0.168
Gnomad SAS
AF:
0.127
Gnomad FIN
AF:
0.155
Gnomad MID
AF:
0.225
Gnomad NFE
AF:
0.177
Gnomad OTH
AF:
0.132
GnomAD2 exomes
AF:
0.147
AC:
36851
AN:
250128
AF XY:
0.151
show subpopulations
Gnomad AFR exome
AF:
0.0353
Gnomad AMR exome
AF:
0.0900
Gnomad ASJ exome
AF:
0.204
Gnomad EAS exome
AF:
0.154
Gnomad FIN exome
AF:
0.141
Gnomad NFE exome
AF:
0.176
Gnomad OTH exome
AF:
0.165
GnomAD4 exome
AF:
0.172
AC:
251988
AN:
1461056
Hom.:
22674
Cov.:
32
AF XY:
0.172
AC XY:
125123
AN XY:
726856
show subpopulations
African (AFR)
AF:
0.0320
AC:
1070
AN:
33474
American (AMR)
AF:
0.0908
AC:
4057
AN:
44704
Ashkenazi Jewish (ASJ)
AF:
0.202
AC:
5272
AN:
26128
East Asian (EAS)
AF:
0.164
AC:
6524
AN:
39686
South Asian (SAS)
AF:
0.145
AC:
12531
AN:
86240
European-Finnish (FIN)
AF:
0.138
AC:
7334
AN:
53170
Middle Eastern (MID)
AF:
0.219
AC:
1264
AN:
5766
European-Non Finnish (NFE)
AF:
0.184
AC:
204239
AN:
1111520
Other (OTH)
AF:
0.161
AC:
9697
AN:
60368
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
11896
23793
35689
47586
59482
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7154
14308
21462
28616
35770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.130
AC:
19807
AN:
152188
Hom.:
1613
Cov.:
32
AF XY:
0.132
AC XY:
9807
AN XY:
74392
show subpopulations
African (AFR)
AF:
0.0366
AC:
1521
AN:
41556
American (AMR)
AF:
0.123
AC:
1874
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.199
AC:
689
AN:
3470
East Asian (EAS)
AF:
0.169
AC:
872
AN:
5174
South Asian (SAS)
AF:
0.127
AC:
611
AN:
4824
European-Finnish (FIN)
AF:
0.155
AC:
1646
AN:
10600
Middle Eastern (MID)
AF:
0.221
AC:
65
AN:
294
European-Non Finnish (NFE)
AF:
0.177
AC:
12010
AN:
67976
Other (OTH)
AF:
0.134
AC:
282
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
866
1732
2597
3463
4329
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
230
460
690
920
1150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.160
Hom.:
5876
Bravo
AF:
0.125
Asia WGS
AF:
0.123
AC:
431
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.050
DANN
Benign
0.71
PhyloP100
-3.8
RBP_binding_hub_radar
0.67
RBP_regulation_power_radar
3.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2287029; hg19: chr19-10916684; COSMIC: COSV58958640; COSMIC: COSV58958640; API